These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
569 related items for PubMed ID: 18405144
1. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes. Inzucchi SE. Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144 [No Abstract] [Full Text] [Related]
2. Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes. Pratley RE. J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():7-11. PubMed ID: 19402254 [No Abstract] [Full Text] [Related]
3. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Standl E, Schnell O. Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474 [No Abstract] [Full Text] [Related]
4. Beyond glycemic control: the effects of incretin hormones in type 2 diabetes. Martin CL. Diabetes Educ; 2008 Feb; 34 Suppl 3():66S-72S. PubMed ID: 18525067 [Abstract] [Full Text] [Related]
5. Which oral agent to use when metformin is no longer effective? Bannon M. QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402 [No Abstract] [Full Text] [Related]
6. Diabetes under control: Understanding oral antidiabetic agents. Longo R. Am J Nurs; 2010 Feb; 110(2):49-52. PubMed ID: 20107402 [No Abstract] [Full Text] [Related]
7. [Pharmacologic treatment of diabetes]. De Montigny P, Clerc C, Descarpentries C. Perspect Infirm; 2006 Feb; 4(2):30-4. PubMed ID: 17184094 [No Abstract] [Full Text] [Related]
8. Clinical decisions. Management of type 2 diabetes. Goldberg RB, Holman R, Drucker DJ. N Engl J Med; 2008 Jan 17; 358(3):293-7. PubMed ID: 18199869 [No Abstract] [Full Text] [Related]
9. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control. Health News; 2005 Feb 17; 11(2):10-1. PubMed ID: 15732153 [No Abstract] [Full Text] [Related]
12. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors. Mathieu C, Bollaerts K. Int J Clin Pract Suppl; 2007 Aug 17; (154):29-37. PubMed ID: 17593275 [Abstract] [Full Text] [Related]
13. Incretins: the novel therapy of type 2 diabetes. Thongtang N, Sriwijitkamol A. J Med Assoc Thai; 2008 Jun 17; 91(6):943-54. PubMed ID: 18697398 [Abstract] [Full Text] [Related]
14. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm. Bailey T. Am J Med; 2013 Sep 17; 126(9 Suppl 1):S10-20. PubMed ID: 23953074 [Abstract] [Full Text] [Related]
15. Incretin-based therapy compared with non-insulin alternatives in elderly patients with type 2 diabetes. Zhao Q, Marcy TR. Consult Pharm; 2013 Aug 17; 28(8):515-8. PubMed ID: 23906896 [Abstract] [Full Text] [Related]
16. What to add in with metformin in type 2 diabetes? Petrie JR, Adler A, Vella S. QJM; 2011 Mar 17; 104(3):185-92. PubMed ID: 21156663 [Abstract] [Full Text] [Related]
17. beta-cell function and anti-diabetic pharmacotherapy. Del Prato S, Bianchi C, Marchetti P. Diabetes Metab Res Rev; 2007 Oct 17; 23(7):518-27. PubMed ID: 17883249 [Abstract] [Full Text] [Related]
18. [The unresolved problems of type 2 diabetes. Diabetology practice]. Rüssmann HJ. Pharm Unserer Zeit; 2010 Mar 17; 39(2):126-32. PubMed ID: 20196045 [No Abstract] [Full Text] [Related]
19. Use of noninsulin antidiabetic medications in hospitalized patients. Kopecky C. Crit Care Nurs Clin North Am; 2013 Mar 17; 25(1):39-53. PubMed ID: 23410645 [Abstract] [Full Text] [Related]
20. Insulin initiation in Type 2 diabetes. Page S. Diabet Med; 2005 Sep 17; 22 Suppl 4():2-5. PubMed ID: 16109011 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]